-transparent.png){kind=logo}
Synthesis, anti-HIV activity and stability studies of 3'-azido-2',3'-dideoxythymidine 5'-fluorophosphate. 1999
D Egron, and
A A Arzumanov, and
N B Dyatkina, and
A Krayevsky, and
J L Imbach, and
A M Aubertin, and
G Gosselin, and
C Périgaud
Laboratoire de Chimie Bioorganique, UMR CNRS-USTL 5625, Université Montpellier II, France.
The synthesis, in vitro anti-HIV activity, and stability studies of AZT 5'-fluorophosphate (F-AZTMP) are reported. The present results demonstrate that such compound is a bioprecursor of its parent 5'-mononucleotide (AZTMP) but its biotransformation does not allow its selective intracellular delivery. Moreover, several attempts were carried out in order to improve the biological activity of this compound by the use of a SATE prodrug strategy.
Related Publications
D Egron, and
A A Arzumanov, and
N B Dyatkina, and
A Krayevsky, and
J L Imbach, and
A M Aubertin, and
G Gosselin, and
C Périgaud
March 2012,
Medicinal chemistry (Shariqah (United Arab Emirates)),
D Egron, and
A A Arzumanov, and
N B Dyatkina, and
A Krayevsky, and
J L Imbach, and
A M Aubertin, and
G Gosselin, and
C Périgaud
July 1999,
Antiviral research,
D Egron, and
A A Arzumanov, and
N B Dyatkina, and
A Krayevsky, and
J L Imbach, and
A M Aubertin, and
G Gosselin, and
C Périgaud
July 1993,
Archiv der Pharmazie,
D Egron, and
A A Arzumanov, and
N B Dyatkina, and
A Krayevsky, and
J L Imbach, and
A M Aubertin, and
G Gosselin, and
C Périgaud
January 1999,
Nucleosides & nucleotides,
D Egron, and
A A Arzumanov, and
N B Dyatkina, and
A Krayevsky, and
J L Imbach, and
A M Aubertin, and
G Gosselin, and
C Périgaud
May 2003,
Antiviral chemistry & chemotherapy,
D Egron, and
A A Arzumanov, and
N B Dyatkina, and
A Krayevsky, and
J L Imbach, and
A M Aubertin, and
G Gosselin, and
C Périgaud
August 2004,
Antiviral research,
D Egron, and
A A Arzumanov, and
N B Dyatkina, and
A Krayevsky, and
J L Imbach, and
A M Aubertin, and
G Gosselin, and
C Périgaud
May 2000,
International journal of pharmaceutics,
D Egron, and
A A Arzumanov, and
N B Dyatkina, and
A Krayevsky, and
J L Imbach, and
A M Aubertin, and
G Gosselin, and
C Périgaud
August 1992,
Journal of medicinal chemistry,
D Egron, and
A A Arzumanov, and
N B Dyatkina, and
A Krayevsky, and
J L Imbach, and
A M Aubertin, and
G Gosselin, and
C Périgaud
April 1991,
Journal of medicinal chemistry,
D Egron, and
A A Arzumanov, and
N B Dyatkina, and
A Krayevsky, and
J L Imbach, and
A M Aubertin, and
G Gosselin, and
C Périgaud
December 1999,
Molecular pharmacology,
